Michael Mauro, MD

Michael Mauro, MD

LeaderMyeloproliferative Neoplasms Program, Memorial Sloan Kettering

Dr. Michael Mauro directs the Myeloproliferative Neoplasms Program at Memorial Sloan-Kettering Cancer Center in New York. He received his medical degree from Dartmouth Medical School and completed his residency at New York-Presbyterian Hospital/Weill Cornell Medical Center. For more than a decade he worked with Dr. Brian Druker at the OHSU Knight Cancer Institute in Portland, Oregon with a focus on leukemia research. His clinical expertise is in Chronic Myelogenous Leukemia; Myelofibrosis; Polycythemia; Thrombocytosis and other myeloproliferative neoplasms.

Related

ASH 2021: Good News for CML Treatment
Chronic Myelogenous Leukemia

ASH 2021: Good News for CML Treatment

Dr. Mauro from Memorial Sloan Kettering shares exciting news about CML treatment from the ASH 2021 conference.

ASH 2021: Good News for CML Treatment
Chronic Myelogenous Leukemia

ASH 2021: Good News for CML Treatment

Dr. Mauro from Memorial Sloan Kettering shares exciting news about CML treatment from the ASH 2021 conference.

ASH 2020 MPN Daily Wrap-Up: New Research and Early Detection
Myeloproliferative Neoplasms

ASH 2020 MPN Daily Wrap-Up: New Research and Early Detection

MPN experts discuss the latest myeloproliferative neoplasm news from ASH 2020, including new research & advances in early detection.

ASH 2020 MPN Daily Wrap-Up: New Research and Early Detection
Myeloproliferative Neoplasms

ASH 2020 MPN Daily Wrap-Up: New Research and Early Detection

MPN experts discuss the latest myeloproliferative neoplasm news from ASH 2020, including new research & advances in early detection.

MPN 101: Definitions, Gene Mutations and What to Expect
Myeloproliferative Neoplasms

MPN 101: Definitions, Gene Mutations and What to Expect

MPN specialists define the three primary types of myeloproliferative neoplasms, various types of gene mutations and what to expect as an MPN patient.

MPN 101: Definitions, Gene Mutations and What to Expect
Myeloproliferative Neoplasms

MPN 101: Definitions, Gene Mutations and What to Expect

MPN specialists define the three primary types of myeloproliferative neoplasms, various types of gene mutations and what to expect as an MPN patient.

CML Expert Discusses How to Protect Yourself From Coronavirus
Chronic Myelogenous Leukemia

CML Expert Discusses How to Protect Yourself From Coronavirus

Leading expert Dr. Michael Mauro takes questions from the CML community on the coronavirus outbreak, and explains the risks for people who are in treatment or have been previously treated for CML.

CML Expert Discusses How to Protect Yourself From Coronavirus
Chronic Myelogenous Leukemia

CML Expert Discusses How to Protect Yourself From Coronavirus

Leading expert Dr. Michael Mauro takes questions from the CML community on the coronavirus outbreak, and explains the risks for people who are in treatment or have been previously treated for CML.